Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02755064 · ClinicalTrials.gov registry record · Phase 1
Relationship Between Gastric Emptying and Glycemic Variability in Type 1 Diabetes Mellitus
A Phase 1 study, sponsored by Adil Bharucha.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT02755064: Completed Phase 1 study, sponsored by Adil Bharucha.
NCT02755064 is a Phase 1 study that has completed, run by Adil Bharucha. The registered enrollment target is 30 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02755064, a Phase 1 study, has completed, sponsored by Adil Bharucha.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
With this study, the investigators hoped to learn if the rate at which food empties from the stomach affects blood sugar values. Using data from this study, we hope to improve our ability to control blood sugars in individuals with type 1 diabetes mellitus.
Primary Outcome
GE was measured by 13C spirulina GEBT. Glycemia was measured with continuous glucose monitoring.
Interventions
- DRUG Placebo IV
- DRUG Placebo Suspension
- DRUG Erythromycin lactobionate
- DRUG [13C]-Spirulina
- DRUG Erythromycin Ethylsuccinate Suspension
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-06 |
| Est. Completion | 2013-11 |
| Phase | Phase 1 |
What the finished NCT02755064 record still lists
NCT02755064 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 5 interventions - of which Placebo IV is the first listed.
NCT02755064 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02755064 about?
NCT02755064 is a clinical study titled "Relationship Between Gastric Emptying and Glycemic Variability in Type 1 Diabetes Mellitus". With this study, the investigators hoped to learn if the rate at which food empties from the stomach affects blood sugar values. Using data from this study, we hope to improve our ability to control blood sugars in individuals with type 1 diabetes mellitus.
What is the current status of trial NCT02755064?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2010-06. Estimated completion is 2013-11.
What interventions are being tested in trial NCT02755064?
The interventions under investigation include: Placebo IV (DRUG), Placebo Suspension (DRUG), Erythromycin lactobionate (DRUG), [13C]-Spirulina (DRUG), Erythromycin Ethylsuccinate Suspension (DRUG).
Who is sponsoring clinical trial NCT02755064?
This trial is sponsored by Adil Bharucha, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02755064's enrollment target sits among peer trials
30 1332nd of 2000 higher than 561 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia